Browse studies

Find your next paid study

1 recruiting study matching your filters

A Pilot Study of Golidocitinib, a JAK1 Inhibitor, in Patients With Mycosis Fungoides/Sézary Syndrome and T-Cell Large Granular Lymphocytic Leukemia (GEMSTONE)

This is an open-label, single-institution pilot study of single-agent golidocitinib enrolling up to 24 patients in two cohorts: a) advanced-stage mycosis fungo…

Mycosis Fungoides/Sezary SyndromeT-cell Large Granular Lymphocytic Leukemia

Estimated

~$10 – $6,250

Washington University School of MedicineNCT07682792